Key result
Copy number variation analysis from next-generation sequencing data identified causative CNVs, increasing the diagnostic yield in patients with muscle diseases.
Why the study?
Does copy number variation analysis increase the diagnostic yield in patients with muscle diseases without a final diagnosis from targeted gene panels?
Observational
Does copy number variation analysis increase the diagnostic yield in patients with muscle diseases without a final diagnosis from targeted gene panels?
Copy number variation analysis from next-generation sequencing data increases the diagnostic yield in patients with unresolved muscle diseases.
CNV analysis of NGS data may boost diagnostic yield in undiagnosed muscle disorders; leaves open need for prospective validation.
OBJECTIVE: Copy number variants (CNVs) were analyzed from next-generation sequencing data, with the aim of improving diagnostic yield in skeletal muscle disorder cases. METHODS: Four publicly available bioinformatic analytic tools were used to analyze CNVs from sequencing data from patients with muscle diseases. The patients were previously analyzed with a targeted gene panel for single nucleotide variants and small insertions and deletions, without achieving final diagnosis. Variants detected by multiple CNV analysis tools were verified with either array comparative genomic hybridization or PCR. The clinical significance of the verified CNVs was interpreted, considering previously identified variants, segregation studies, and clinical information of the patient cases. RESULTS: gene and a Becker muscular dystrophy causing deletion in the dystrophin gene. CONCLUSIONS: Causative CNVs were identified proving that analysis of CNVs is essential for increasing the diagnostic yield in muscle diseases. Complex severe muscular dystrophy phenotypes can be the result of different mutation types but also of the compound effect of 2 different genetic diseases.
No takes yet. Share an insight, caveat, or question.
Välipakka et al. (2017) conducted an observational in Muscle diseases. Copy number variation (CNV) analysis from next-generation sequencing data was evaluated on Diagnostic yield. Copy number variation analysis from next-generation sequencing data identified causative CNVs, increasing the diagnostic yield in patients with muscle diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: